2,047 reports of this reaction
9.8% of all SULFUR reports
#3 most reported adverse reaction
ERYTHEMA is the #3 most commonly reported adverse reaction for SULFUR, manufactured by Alchemee, LLC. There are 2,047 FDA adverse event reports linking SULFUR to ERYTHEMA. This represents approximately 9.8% of all 20,945 adverse event reports for this drug.
Patients taking SULFUR who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ERYTHEMA is moderately reported among SULFUR users, representing a notable but not dominant share of adverse events.
In addition to erythema, the following adverse reactions have been reported for SULFUR:
The following drugs have also been linked to erythema in FDA adverse event reports:
ERYTHEMA has been reported as an adverse event in 2,047 FDA reports for SULFUR. This does not prove causation, but indicates an association observed in post-market surveillance data.
ERYTHEMA accounts for approximately 9.8% of all adverse event reports for SULFUR, making it one of the most commonly reported side effect.
If you experience erythema while taking SULFUR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.